Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5283 | 1578 | 41.1 | 90% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
168 | 21544 | ASYMMETRIC DIMETHYLARGININE//ENDOTHELIUM//ADMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ASYMMETRIC DIMETHYLARGININE | Author keyword | 452 | 65% | 27% | 427 |
2 | ADMA | Author keyword | 270 | 66% | 16% | 253 |
3 | DIMETHYLARGININE DIMETHYLAMINOHYDROLASE | Author keyword | 201 | 86% | 6% | 101 |
4 | SYMMETRIC DIMETHYLARGININE | Author keyword | 87 | 81% | 3% | 52 |
5 | ASYMMETRIC DIMETHYLARGININE ADMA | Author keyword | 65 | 70% | 3% | 54 |
6 | DDAH | Author keyword | 56 | 74% | 3% | 42 |
7 | DIMETHYLARGININES | Author keyword | 38 | 84% | 1% | 21 |
8 | METHYLARGININES | Author keyword | 38 | 86% | 1% | 19 |
9 | ASYMMETRICAL DIMETHYLARGININE | Author keyword | 35 | 61% | 2% | 37 |
10 | DIMETHYLARGININE | Author keyword | 32 | 65% | 2% | 31 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ASYMMETRIC DIMETHYLARGININE | 452 | 65% | 27% | 427 | Search ASYMMETRIC+DIMETHYLARGININE | Search ASYMMETRIC+DIMETHYLARGININE |
2 | ADMA | 270 | 66% | 16% | 253 | Search ADMA | Search ADMA |
3 | DIMETHYLARGININE DIMETHYLAMINOHYDROLASE | 201 | 86% | 6% | 101 | Search DIMETHYLARGININE+DIMETHYLAMINOHYDROLASE | Search DIMETHYLARGININE+DIMETHYLAMINOHYDROLASE |
4 | SYMMETRIC DIMETHYLARGININE | 87 | 81% | 3% | 52 | Search SYMMETRIC+DIMETHYLARGININE | Search SYMMETRIC+DIMETHYLARGININE |
5 | ASYMMETRIC DIMETHYLARGININE ADMA | 65 | 70% | 3% | 54 | Search ASYMMETRIC+DIMETHYLARGININE+ADMA | Search ASYMMETRIC+DIMETHYLARGININE+ADMA |
6 | DDAH | 56 | 74% | 3% | 42 | Search DDAH | Search DDAH |
7 | DIMETHYLARGININES | 38 | 84% | 1% | 21 | Search DIMETHYLARGININES | Search DIMETHYLARGININES |
8 | METHYLARGININES | 38 | 86% | 1% | 19 | Search METHYLARGININES | Search METHYLARGININES |
9 | ASYMMETRICAL DIMETHYLARGININE | 35 | 61% | 2% | 37 | Search ASYMMETRICAL+DIMETHYLARGININE | Search ASYMMETRICAL+DIMETHYLARGININE |
10 | DIMETHYLARGININE | 32 | 65% | 2% | 31 | Search DIMETHYLARGININE | Search DIMETHYLARGININE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADMA | 449 | 79% | 18% | 291 |
2 | DIMETHYLAMINOHYDROLASE | 418 | 83% | 15% | 234 |
3 | ASYMMETRIC DIMETHYLARGININE | 172 | 37% | 23% | 367 |
4 | SYMMETRIC DIMETHYLARGININE | 118 | 65% | 7% | 113 |
5 | ASYMMETRIC DIMETHYLARGININE ADMA | 89 | 51% | 8% | 123 |
6 | ENDOGENOUS INHIBITOR | 78 | 31% | 14% | 215 |
7 | PLASMA ASYMMETRIC DIMETHYLARGININE | 50 | 77% | 2% | 34 |
8 | OXIDE SYNTHASE PATHWAY | 31 | 82% | 1% | 18 |
9 | OXIDE SYNTHASE INHIBITOR | 27 | 33% | 4% | 68 |
10 | DIMETHYLAMINOHYDROLASE ACTIVITY | 26 | 100% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
L-Homoarginine and cardiovascular disease | 2015 | 7 | 26 | 50% |
Homoarginine in the renal and cardiovascular systems | 2015 | 6 | 61 | 56% |
The role of asymmetric and symmetric dimethylarginines in renal disease | 2011 | 53 | 120 | 88% |
Nitric oxide deficiency in chronic kidney disease | 2008 | 146 | 123 | 61% |
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk | 2009 | 77 | 52 | 88% |
Dimethylarginines ADMA and SDMA: The Real Water-Soluble Small Toxins? | 2014 | 8 | 71 | 83% |
Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease Markers, Mediators, and Regulators? | 2012 | 31 | 166 | 78% |
Cardiovascular biology of the asymmetric dimethylarginine: Dimethylarginine dimethylaminohydrolase pathway | 2004 | 323 | 82 | 76% |
The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis | 2011 | 52 | 188 | 62% |
Asymmetric dimethylarginine and critical illness | 2014 | 6 | 40 | 85% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NITR OXIDE SIGNALLING GRP | 8 | 100% | 0.3% | 5 |
2 | EXPT CLIN PHARMACOLCLIN PHARMACOL UNIT | 6 | 100% | 0.3% | 4 |
3 | ARBEITSGRP KLIN PHARMAKOL | 4 | 67% | 0.3% | 4 |
4 | BIOSYST REGULATCHIYODA KU | 4 | 67% | 0.3% | 4 |
5 | MED CELLULAR MOLEC SCI | 4 | 75% | 0.2% | 3 |
6 | SCI MENTAL HLTH ADVERS UNIT | 4 | 75% | 0.2% | 3 |
7 | UNIV VASC MED | 4 | 38% | 0.5% | 8 |
8 | EXPT NEUROPEDIAT | 3 | 100% | 0.2% | 3 |
9 | HLTH PROMOT FAMILY CARE | 3 | 40% | 0.4% | 6 |
10 | INTERNAL MED RENAL HYPERTENS DIS 4 | 3 | 60% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000178792 | POLYASPARTOYL L ARGININE//BEIJING S HYDRONE PEPTIDES//CHAIR SEMEIOL MED METHODOL |
2 | 0.0000067513 | ARGININE METHYLATION//CARM1//PROTEIN ARGININE METHYLTRANSFERASE |
3 | 0.0000064450 | CITRULLINE//HUBEI ANIM NUTR FEED SCI//HUNAN ENGN ANIM POULTRY SCI |
4 | 0.0000057135 | ARGINASE//NOR NOHA//ARGINASE II |
5 | 0.0000051698 | FLOW MEDIATED DILATION//FLOW MEDIATED DILATATION//ENDOTHELIAL FUNCTION |
6 | 0.0000046663 | ARGININE DEIMINASE//ARGININE DEPRIVATION//ADI PEG20 |
7 | 0.0000045704 | NORMAL PATHOL PHYSIOL//NO DEFICIENCY//L NAME HYPERTENSION |
8 | 0.0000040427 | ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE//ENOS GENE//ENOS POLYMORPHISM |
9 | 0.0000038824 | ZENTRUM PHARMAKOL//URINARY NITRITE NITRATE//AIDS PATHOGENESIS MOL THER EUT |
10 | 0.0000037159 | NEBIVOLOL//VASODILATING BETA BLOCKERS//NEBIVOLOL HYDROCHLORIDE |